Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Other Accumulated Expenses (2016 - 2025)

Alkermes (ALKS) has disclosed Other Accumulated Expenses for 15 consecutive years, with $99.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 44.26% to $99.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $99.2 million, a 44.26% increase, with the full-year FY2025 number at $99.2 million, up 44.26% from a year prior.
  • Other Accumulated Expenses was $99.2 million for Q4 2025 at Alkermes, up from $79.8 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $117.1 million in Q3 2022 to a low of $62.5 million in Q1 2021.
  • A 5-year average of $87.8 million and a median of $89.2 million in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: soared 88.66% in 2021, then dropped 25.12% in 2024.
  • Alkermes' Other Accumulated Expenses stood at $75.5 million in 2021, then soared by 43.23% to $108.2 million in 2022, then fell by 15.12% to $91.8 million in 2023, then decreased by 25.12% to $68.7 million in 2024, then soared by 44.26% to $99.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Other Accumulated Expenses are $99.2 million (Q4 2025), $79.8 million (Q3 2025), and $90.0 million (Q2 2025).